Can AI help create “smart borders” between countries?
In 2016, border patrols in Greece, Latvia and Hungary received a prototype for an AI-powered lie detector to help screen asylum seekers. The detector, called iBorderCtrl, was funded by the European Commission in hopes to eventually mitigate refugee crises like the one sparked by the Syrian civil war a year prior.
iBorderCtrl, which analyzes micro expressions in the face, received but one slice of the Commission’s €34.9 billion border control and migration management budget. Still in development is the more ambitious EuMigraTool, a predictive AI system that will process internet news and social media posts to estimate not only the number of migrants heading for a particular country, but also the “risks of tensions between migrants and EU citizens.”
Both iBorderCtrl and EuMigraTool are part of a broader trend: the growing digitization of migration-related technologies. Outside of the EU, in refugee camps in Jordan, the United Nations introduced iris scanning software to distribute humanitarian aid, including food and medicine. And in the United States, Customs and Border Protection has attempted to automate its services through an app called CBP One, which both travelers and asylum seekers can use to apply for I-94 forms, the arrival-departure record cards for people who are not U.S. citizens or permanent residents.
According to Koen Leurs, professor of gender, media and migration studies at Utrecht University in the Netherlands, we have arrived at a point where migration management has become so reliant on digital technology that the former can no longer be studied in isolation from the latter. Investigating this reliance for his new book, Digital Migration, Leurs came to the conclusion that applications like those mentioned above are more often than not a double-edged sword, presenting both benefits and drawbacks.
There has been “a huge acceleration” in the way digital technologies “dehumanize people,” says Koen Leurs, professor of gender, media and migration studies at Utrecht University in the Netherlands. Governments treat asylum seekers as test subjects for new inventions, all along the borders of the developed world.
On the one hand, digital technology can make migration management more efficient and less labor intensive, enabling countries to process larger numbers of people in a time when global movement is on the rise due to globalization and political instability. Leurs also discovered that informal knowledge networks such as Informed Immigrant, an online resource that connects migrants to social workers and community organizers, have positively impacted the lives of their users. The same, Leurs notes, is true of platforms like Twitter, Facebook, and WhatsApp, all of which migrants use to stay in touch with each other as well as their families back home. “The emotional support you receive through social media is something we all came to appreciate during the COVID pandemic,” Leurs says. “For refugees, this had already been common knowledge for years.”
On the flipside, automatization of migration management – particularly through the use of AI – has spawned extensive criticism from human rights activists. Sharing their sentiment, Leurs attests that many so-called innovations are making life harder for migrants, not easier. He also says there has been “a huge acceleration” in the way digital technologies “dehumanize people,” and that governments treat asylum seekers as test subjects for new inventions, all along the borders of the developed world.
In Jordan, for example, refugees had to scan their irises in order to collect aid, prompting the question of whether such measures are ethical. Speaking to Reuters, Petra Molnar, a fellow at Harvard University’s Berkman Klein Center for Internet and Society, said that she was troubled by the fact that this experiment was done on marginalized people. “The refugees are guinea pigs,” she said. “Imagine what would happen at your local grocery store if all of a sudden iris scanning became a thing,” she pointed out. “People would be up in arms. But somehow it is OK to do it in a refugee camp.”
Artificial intelligence programs have been scrutinized for their unreliability, their complex processing, thwarted by the race and gender biases picked up from training data. In 2019, a female reporter from The Intercept tested iBorderCtrl and, despite answering all questions truthfully, was accused by the machine of lying four out of 16 times. Had she been waiting at checkpoint on the Greek or Latvian border, she would have been flagged for additional screening – a measure that could jeopardize her chance of entry. Because of its biases, and the negative press that this attracted, iBorderCtrl did not move past its test phase.
While facial recognition caused problems on the European border, it was helpful in Ukraine, where programs like those developed by software company Clearview AI are used to spot Russian spies, identify dead soldiers, and check movement in and out of war zones.
In April 2021, not long after iBorderCtrl was shut down, the European Commission proposed the world’s first-ever legal framework for AI regulation: the Artificial Intelligence Act. The act, which is still being developed, promises to prevent potentially “harmful” AI practices from being used in migration management. In the most recent draft, approved by the European Parliament’s Liberties and Internal Market committees, the ban included emotion recognition systems (like iBorderCtrl), predictive policing systems (like EUMigraTool), and biometric categorization systems (like iris scanners). The act also stipulates that AI must be subject to strict oversight and accountability measures.
While some worry the AI Act is not comprehensive enough, others wonder if it is in fact going too far. Indeed, many proponents of machine learning argue that, by placing a categorical ban on certain systems, governments will thwart the development of potentially useful technology. While facial recognition caused problems on the European border, it was helpful in Ukraine, where programs like those developed by software company Clearview AI are used to spot Russian spies, identify dead soldiers, and check movement in and out of war zones.
Instead of flat-out banning AI, why not strive to make it more reliable? “One of the most compelling arguments against AI is that it is inherently biased,” says Vera Raposo, an assistant professor of law at NOVA University in Lisbon specializing in digital law. “In truth, AI itself is not biased; it becomes biased due to human influence. It seems that complete eradication of biases is unattainable, but mitigation is possible. We can strive to reduce biases by employing more comprehensive and unbiased data in AI training and encompassing a wider range of individuals. We can also work on developing less biased algorithms, although this is challenging given that coders, being human, inherently possess biases of their own.”
AI is most effective when it enhances human performance rather than replacing it.
Accessibility is another obstacle that needs to be overcome. Leurs points out that, in migration management, AI often functions as a “black box” because the migration officers operating it are unable to comprehend its complex decision-making process and thus unable to scrutinize its results. One solution to this problem is to have law enforcement work closely with AI experts. Alternatively, machine learning could be limited to gathering and summarizing information, leaving evaluation of that information to actual people.
Raposo agrees AI is most effective when it enhances human performance rather than replacing it. On the topic of transparency, she does note that making an AI that is both sophisticated and easy to understand is a little bit like having your cake and eating it too. “In numerous domains,” she explains, “we might need to accept a reduced level of explainability in exchange for a high degree of accuracy (assuming we cannot have both).” Using healthcare as an analogy, she adds that “some medications work in ways not fully understood by either doctors or pharma companies, yet persist due to demonstrated efficacy in clinical trials.”
Leurs believes digital technologies used in migration management can be improved through a push for more conscientious research. “Technology is a poison and a medicine for that poison,” he argues, which is why new tech should be developed with its potential applications in mind. “Ethics has become a major concern in recent years. Increasingly, and particularly in the study of forced migration, researchers are posing critical questions like ‘what happens with the data that is gathered?’ and ‘who will this harm?’” In some cases, Leurs thinks, that last question may need to be reversed: we should be thinking about how we can actively disarm oppressive structures. “After all, our work should align with the interests of the communities it is going to affect.”
Story by Big Think
Our gut microbiome plays a substantial role in our health and well-being. Most research, however, focuses on bacteria, rather than the viruses that hide within them. Now, research from the University of Copenhagen, newly published in Nature Microbiology, found that people who live past age 100 have a greater diversity of bacteria-infecting viruses in their intestines than younger people. Furthermore, they found that the viruses are linked to changes in bacterial metabolism that may support mucosal integrity and resistance to pathogens.
The microbiota and aging
In the early 1970s, scientists discovered that the composition of our gut microbiota changes as we age. Recent studies have found that the changes are remarkably predictable and follow a pattern: The microbiota undergoes rapid, dramatic changes as toddlers transition to solid foods; further changes become less dramatic during childhood as the microbiota strikes a balance between the host and the environment; and as that balance is achieved, the microbiota remains mostly stable during our adult years (ages 18-60). However, that stability is lost as we enter our elderly years, and the microbiome undergoes dramatic reorganization. This discovery led scientists to question what causes this change and what effect it has on health.
Centenarians have a distinct gut community enriched in microorganisms that synthesize potent antimicrobial molecules that can kill multidrug-resistant pathogens.
“We are always eager to find out why some people live extremely long lives. Previous research has shown that the intestinal bacteria of old Japanese citizens produce brand-new molecules that make them resistant to pathogenic — that is, disease-promoting — microorganisms. And if their intestines are better protected against infection, well, then that is probably one of the things that cause them to live longer than others,” said Joachim Johansen, a researcher at the University of Copenhagen.
In 2021, a team of Japanese scientists set out to characterize the effect of this change on older people’s health. They specifically wanted to determine if people who lived to be over 100 years old — that is, centenarians — underwent changes that provided them with unique benefits. They discovered centenarians have a distinct gut community enriched in microorganisms that synthesize potent antimicrobial molecules that can kill multidrug-resistant pathogens, including Clostridioides difficile and Enterococcus faecium. In other words, the late-life shift in microbiota reduces an older person’s susceptibility to common gut pathogens.
Viruses can change alter the genes of bacteria
Although the late-in-life microbiota change could be beneficial to health, it remained unclear what facilitated this shift. To solve this mystery, Johansen and his colleagues turned their attention to an often overlooked member of the microbiome: viruses. “Our intestines contain billions of viruses living inside bacteria, and they could not care less about human cells; instead, they infect the bacterial cells. And seeing as there are hundreds of different types of bacteria in our intestines, there are also lots of bacterial viruses,” said Simon Rasmussen, Johansen’s research advisor.
Centenarians had a more diverse virome, including previously undescribed viral genera.
For decades, scientists have explored the possibility of phage therapy — that is, using viruses that infect bacteria (called bacteriophages or simply phages) to kill pathogens. However, bacteriophages can also enhance the bacteria they infect. For example, they can provide genes that help their bacterial host attack other bacteria or provide new metabolic capabilities. Both of these can change which bacteria colonize the gut and, in turn, protect against certain disease states.
Intestinal viruses give bacteria new abilities
Johansen and his colleagues were interested in what types of viruses centenarians had in their gut and whether those viruses carried genes that altered metabolism. They compared fecal samples of healthy centenarians (100+ year-olds) with samples from younger patients (18-100 year-olds). They found that the centenarians had a more diverse virome, including previously undescribed viral genera.
They also revealed an enrichment of genes supporting key steps in the sulfate metabolic pathway. The authors speculate that this translates to increased levels of microbially derived sulfide, which may lead to health-promoting outcomes, such as supporting mucosal integrity and resistance to potential pathogens.
“We have learned that if a virus pays a bacterium a visit, it may actually strengthen the bacterium. The viruses we found in the healthy Japanese centenarians contained extra genes that could boost the bacteria,” said Johansen.
Simon Rasmussen added, “If you discover bacteria and viruses that have a positive effect on the human intestinal flora, the obvious next step is to find out whether only some or all of us have them. If we are able to get these bacteria and their viruses to move in with the people who do not have them, more people could benefit from them.”
This article originally appeared on Big Think, home of the brightest minds and biggest ideas of all time.
Sign up for Big Think’s newsletter
Embrace the mess: how to choose which scientists to trust
It’s no easy task these days for people to pick the scientists they should follow. According to a recent poll by NORC at the University of Chicago, only 39 percent of Americans have a "great deal" of confidence in the scientific community. The finding is similar to Pew research last year showing that 29 percent of Americans have this level of confidence in medical scientists.
Not helping: All the money in science. Just 20 percent of Pew’s survey respondents think scientists are transparent about conflicts of interest with industry. While this issue is common to many fields, the recent gold rush to foot the bill for research on therapies for healthy aging may be contributing to the overall sense of distrust. “There’s a feeling that at some point, the FDA may actually designate aging as a disease,” said Pam Maher, a neuroscientist who studies aging at Salk Institute. “That may be another impetus for a lot of these companies to start up.”
But partnering with companies is an important incentive for researchers across biomedical fields. Many scientists – with and without financial ties and incentives – are honest, transparent and doing important, inspiring work. I asked more than a dozen bioethicists and researchers in aging how to spot the scientists who are searching for the truth more than money, ego or fame.
Avoid Scientists Who Sound Overly Confident in messaging to the public. Some multi-talented scientists are adept at publishing in both top journals and media outlets. They’re great at dropping science without the confusing jargon, in ways the public can enjoy and learn from.
But do they talk in simple soundbites, painting scientific debates in pastels or black and white when colleagues use shades of gray? Maybe they crave your attention more than knowledge seeking. “When scientists speak in a very unnuanced way, that can be irresponsible,” said Josephine Johnston, a bioethicist at the Hastings Center.
Scientists should avoid exaggerations like “without a doubt” and even “we know” – unless they absolutely do. “I feel like there’s more and more hyperbole and attention seeking…[In aging research,] the loudest voices in the room are the fringe people,” said the biogenerontologist Matt Kaeberlein.
Separate Hype from Passion. Scientists should be, need to be passionate, Johnston explained. In the realm of aging, for example, Leonard Guarente, an MIT biologist and pioneer in the field of aging, told me about his belief that longer lifespans would make for a better world.
Instead of expecting scientists to be lab-dwelling robots, we should welcome their passion. It fuels scientific dedication and creativity. Fields like aging, AI and gene editing inspire the imaginations of the public and scientists alike. That’s not a bad thing.
But it does lay fertile ground for overstatements, such as claims by some that the first 1,000-year-old has already been born. If it sounds like sci-fi, it’s probably sci-fi.
Watch Out for Cult Behavior, some experts told me. Follow scientists who mix it up and engage in debates, said NYU bioethicist Arthur Caplan, not those who hang out only with researchers in the same ideological camp.
Look for whether they’re open to working with colleagues who don’t share their views. Through collaboration, they can resolve conflicting study results and data, said Danica Chen, a biologist at UC Berkeley. We should trust science as long as it doesn’t trust itself.
Messiness is Good. You want to find and follow scientists who’ve published research over the years that does not tell a clean story. “Our goal is to disprove our models,” Kaeberlein said. Scientific findings and views should zig and zag as their careers – and science – progress.
Follow scientists who write and talk publicly about new evidence that’s convinced them to reevaluate their own positions. Who embrace the inherent messiness of science – that’s the hallmark of an honest researcher.
The flipside is a very linear publishing history. Some scientists have a pet theory they’ve managed to support with more and more evidence over time, like a bricklayer gradually, flawlessly building the prettiest house in the neighborhood. Too pretty.
There’s a dark side to this charming simplicity: scientists sometimes try and succeed at engineering the very findings they’re hoping to get, said Charles Brenner, a biochemist at City of Hope National Medical Center.
These scientists “try to prove their model and ignore data that doesn’t fit their model because everybody likes a clean story,” Kaeberlein said. “People want to become famous,” said Samuel Klein, a biologist at Washington University. “So there’s always that bias to try to get positive results.”
Don’t Overvalue Credentials. Just because a scientist works at a top university doesn’t mean they’re completely trustworthy. “The institution means almost nothing,” Kaeberlein said.
Same goes for publishing in top journals, Kaeberlein added. “There’s an incentive structure that favors poor quality science and irreproducible results in high profile journals.”
Traditional proxies for credibility aren’t quite as reliable these days. Shortcuts don’t cut it anymore; you’ve got to scrutinize the actual research the scientist is producing. “You have to look at the literature and try to interpret it for yourself,” said Rafael de Cabo, a scientist at the National Institute on Aging, run by the U.S. National Institutes of Health. Or find journalists you trust to distill this information for you, Klein suggested.
Consider Company Ties. Companies can help scientists bring their research to the public more directly and efficiently than the slower grind of academia, where “the opportunities and challenges weren’t big enough for me,” said Kaeberlein, who left the University of Washington earlier this year.
"It’s generally not universities that can take technology through what we call the valley of death,” Brenner said. “There are rewards associated with taking risks.”
Many scientists are upfront about their financial conflicts of interest – sometimes out of necessity. “At a place like Duke, our conflicts of interest are very closely managed, said Matthew Hirschey, who researchers metabolism at Duke’s Molecular Physiology Institute. “We have to be incredibly explicit about our partnerships.”
But the willingness to disclose conflicts doesn’t necessarily mean the scientist is any less biased. Those conflicts can still affect their views and outcomes of their research, said Johnston, the Hastings bioethicist.
“The proof is in the pudding, and it’s got to be done by people who are not vested in making money off the results,” Klein said. Worth noting: even if scientists eschew companies, they’re almost always financially motivated to get grants for their research.
Bottom line: lots of scientists work for and with companies, and many are highly trustworthy leaders in their fields. But if a scientist is in thick with companies and checks some of the other boxes on this list, their views and research may be compromised.